Jiangsu Zenji Pharmaceuticals Ltd.

MENU

product service 产品服务

Independent Variety Manufacturing
Zenji has a number of products that have been approved by China NMPA, US FDA, EU EMA and Japan PMDA. The products cover many domestic provinces and cities, and are exported to more than 20 countries and regions including the US, EU, Japan, South Korea, India.
CMO/CRO (Medical Contract Outsourcing Organization)
  • Custom synthesis service
  • API declaration service
  • Commissioned processing service

Zenji provides comprehensive customized services for domestic and foreign pharmaceutical R & D companies, including the development and production of pharmaceutical intermediates and APIs. We accept projects in all stages, from the initial stage of scheme formation to laboratory-scale synthesis, sample verification, process development, pilot scale, and industrial production.

Zenji provides drug substance R & D declaration services throughout the entire drug development process. Can provide one-stop outsourcing services from process route development and verification, analysis method development and verification, process improvement and application registration.

Under the market licensor (MAH) system, Zenji accepts chemical bulk drug processing services from domestic and foreign scientific research institutions, enterprises and individuals, and can provide R & D, registration, and production services for the successful listing of products according to customer needs.

Pharmaceutical intermediates and API
Zenji has successfully developed a series of few drugs such as antiviral, antitumor, cardio-cerebrovascular and digestive drugs, etc., and can cater the global pharmaceutical companies with a large number of raw materials, registered starting materials, GMP advanced intermediates and APIs.
Contact us
0512-66167993
zenji@zenjipharma.com
自主品种制造
正济拥有多个已获得中国CFDA、美国FDA、欧盟EMA及日本PMDA批准的产品,产品覆盖国内多个省市,远销美国、欧盟、日本、韩国、印度等20多个国家和地区
CMO/CRO(医药合同外包组织)
  • 定制合成服务
  • API申报服务
  • 委托加工服务

正济为国内外药物研发企业提供全面定制服务,包括医药中间体、API的开发与生产。我们接受所有阶段的项目,包括方案形成的初始阶段到实验室规模合成、样品验证、工艺开发、中试,直至工业化生产

正济为国内外药物研发企业提供全面定制服务,包括医药中间体、API的开发与生产。我们接受所有阶段的项目,包括方案形成的初始阶段到实验室规模合成、样品验证、工艺开发、中试,直至工业化生产

正济为国内外药物研发企业提供全面定制服务,包括医药中间体、API的开发与生产。我们接受所有阶段的项目,包括方案形成的初始阶段到实验室规模合成、样品验证、工艺开发、中试,直至工业化生产

医药中间体及API
正济目前已经成功开发了肝病、抗肿瘤类、心脑血管类、降糖类等一系列最新药物的合成工艺,可以为全球制药公司提供大量的初始原料、注册起始物料、GMP高级中间体及API
查看产品
联系方式:0517-87216688
XML 地图